ARA-290 – 20mg

Highlights

• Erythropoietin-based peptide studied for anti-inflammatory effects.
• Research shows potential in glucose, lipid, and nerve regulation.
• Non-erythropoietic; for research use only.

Description

ARA-290 is a synthetic peptide derived from erythropoietin’s beta-helix region, studied for its role in modulating inflammatory pathways through innate repair receptors. Research indicates potential benefits in reducing HbA1c, improving lipid profiles, alleviating neuropathic discomfort, and supporting tissue recovery, without influencing red blood cell production. For research use only; not for human consumption.